CTT on Renogram as an Early Marker of Significant Obstruction in Uretero-pelvic Junction Syndrome

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age4-8
SponsorCentre Hospitalier Universitaire de la Réunion

About this trial

Cortical transit time on diuretic renogram as an early marker of significant obstruction in antenatally detected uretero-pelvic junction syndrome

Eligibility criteria

Qualifiers

Aged of 4 to 8 weeks of life

Presenting an ureteropelvic junction obstruction (UPJO) detected before birth by ultrasound

Presenting an UPJO, defined by an Antero-Posterior Renal Pelvic Diameter greater or equal to 15 mm, confirmed by ultrasound post-natally between the 1st and 15th day of life

Presenting a unilateral UPJO

Disqualifiers

A bilateral UPJO

An ureteral dilatation

An associated contralateral uropathy

A solitary kidney

Trial design

Treatments tested in this trial

  • ultrasonography
  • diuretic renography

Treatment groups

75 Participants
are divided into 1 treatment group

Locations

5
CHU de Bordeaux33076, Bordeaux France
CHU de Limoges87000, Limoges France
CHU de Nantes44000, Nantes France
CHU de Rennes35023, Rennes France

Sponsors and collaborators

Centre Hospitalier Universitaire de la Réunion

Lead sponsor